Please login or create an account. If you do not have access to this content, you will be shown a 30 second preview and licensing options.

  • Presentation

Medical Pearls by Dirk M. Elston, MD

Description

In this presentation, Dr. Dirk M. Elston shares practical medical pearls and insights gleaned from his experience and observations in dermatology. He emphasizes strategies for managing painful thiosulfate injections by diluting the solution to alleviate discomfort. Dr. Elston discusses treatment methods for keratoacanthomas, advocating for chemotherapy wraps combined with low-dose oral methotrexate or acitretin and detailed procedural tips for effective treatment. He highlights the importance of recognizing the adverse effects of corticosteroids, particularly in patients developing steroid atrophy, and suggests alternatives like topical JAK inhibitors and anesthetics to alleviate pain. Additionally, he underlines the need for careful monitoring of patients on drugs like cyclosporine and discusses the economic advantages of inexpensive alternatives like methotrexate. The presentation also touches on modern biologics and their application, chronic urticaria management, and how to address patients' concerns over mishandled prescriptions, emphasizing thorough patient education and detailed monitoring. Dr. Elston encapsulates his talk with practical advice for diagnosing and managing various dermatologic conditions, highlighting the significance of adequate dosing, cultural competence, and the role of emerging therapies in patient care.

View more

Conclusions

  • Using diluted thiosulfate injections can reduce patient pain while maintaining efficacy.
  • Chemo-wraps combined with low-dose methotrexate or acitretin are effective for treating eruptive keratoacanthomas.
  • Intralesional 5-FU or methotrexate can offer alternatives for patients who are poor surgical candidates.
  • Addressing steroid atrophy is crucial in managing severe pruritus in patients.
  • Topical pramoxine and JAK inhibitors are preferred as alternatives when patients can't tolerate topical calcineurin inhibitors.
  • Calcium channel blockers are a common cause of eczematous drug eruptions and should be evaluated in patients with new onset eczema.
  • A rapid initial dose of amlodipine can help manage refractory eczema effectively.
  • High doses of azathioprine may be necessary as many patients metabolize it quickly, thus it should be monitored appropriately.
  • Mycophenolate is an effective treatment for refractory eczema and blood levels need to be monitored for efficacy.
  • Patients on biologics may benefit from a brief course of methotrexate to manage neutralizing antibodies.
  • Doxepin is effective for chronic urticaria and can be used at higher doses when needed.
  • Thuzar Shin, MD
  • Dorinda Shelley, MD
  • Omar Noor, MD
  • Dirk M. Elston, MD
  • LIBERTY 1994